|
2018 Journal Article PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa Burr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Taylor, Steven L., Bowler, Simon D., Keating, Rebecca L., Martin, Megan L., Hasnain, Sumaira Z. and McGuckin, Michael A. (2018). PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa . PLoS ONE, 13 (8) e0202296, e0202296. doi: 10.1371/journal.pone.0202296 |
|
2018 Journal Article Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategyTaylor, Steven L., Leong, Lex E. X., Mobegi, Fredrick M., Choo, Jocelyn M., Burr, Lucy D., Wesselingh, Steve and Rogers, Geraint B. (2018). Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy. Multidisciplinary Respiratory Medicine, 13 (S1) 30, 30. doi: 10.1186/s40248-018-0140-9 |
|
2018 Journal Article Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasisChoo, Jocelyn M., Abell, Guy C. J., Thomson, Rachel, Morgan, Lucy, Waterer, Grant, Gordon, David L., Taylor, Steven L., Leong, Lex E. X., Wesselingh, Steve L., Burr, Lucy D. and Rogers, Geraint B. (2018). Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis. mSphere, 3 (2) e00103-18, e00103-18. doi: 10.1128/mSphere.00103-18 |
|
2016 Journal Article Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trialBurr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Hamilton, Brett R., Pool, Gertruida F., Taylor, Steven L., Venter, Deon, Bowler, Simon D., Biga, Sally and McGuckin, Michael A. (2016). Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trial. Annals of the American Thoracic Society, 13 (10), 1697-1703. doi: 10.1513/AnnalsATS.201601-044OC |
|
2016 Journal Article Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samplesScoleri, Gianny P., Choo, Jocelyn M., Leong, Lex E. X., Goddard, Thomas R., Shephard, Lisa, Burr, Lucy D., Bastian, Ivan, Thomson, Rachel M. and Rogers, Geraint B. (2016). Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples. Journal of Clinical Microbiology, 54 (9), 2395-2398. doi: 10.1128/JCM.01410-16 |
|
2016 Journal Article FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasisTaylor, Steven L., Woodman, Richard J., Chen, Alice C. H., Burr, Lucy D., Gordon, David L., McGuckin, Michael A., Wesselingh, Steve and Rogers, Geraint B. (2016). FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. Thorax, 72 (4), 304-310. doi: 10.1136/thoraxjnl-2016-208775 |
|
2015 Journal Article Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisTaylor, Steven L., Rogers, Geraint B., Chen, Alice C.-H., Burr, Lucy D., McGuckin, Michael A. and Serisier, David J. (2015). Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Annals of the American Thoracic Society, 12 (5), 701-707. doi: 10.1513/AnnalsATS.201411-513OC |
|
2015 Journal Article Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activationChen, Alice C.-H., Martin, Megan L., Lourie, Rohan, Rogers, Geraint B., Burr, Lucy D., Hasnain, Sumaira Z., Bowler, Simon D., McGuckin, Michael A. and Serisier, David J. (2015). Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS ONE, 10 (3) e0119325, e0119325. doi: 10.1371/journal.pone.0119325 |
|
2014 Journal Article The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trialRogers, Geraint B., Bruce, Kenneth D., Martin, Megan L., Burr, Lucy D. and Serisier, David J. (2014). The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. The Lancet Respiratory Medicine, 2 (12), 988-996. doi: 10.1016/S2213-2600(14)70213-9 |
|
2014 Journal Article A novel microbiota stratification system predicts future exacerbations in bronchiectasisRogers, Geraint B., Zain, Nur Masirah M., Bruce, Kenneth D., Burr, Lucy D., Chen, Alice C., Rivett, Damian W., McGuckin, Michael A. and Serisier, David J. (2014). A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Annals of the American Thoracic Society, 11 (4), 496-503. doi: 10.1513/AnnalsATS.201310-335OC |
|
2014 Journal Article Miscellaneous antibacterial drugsBurr, Lucy, Cunningham, Jordan and Serisier, David (2014). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 36, 363-380. doi: 10.1016/B978-0-444-63407-8.00026-5 |
|
2012 Journal Article An unusual radiological presentation of pulmonary Langerhans' cell histiocytosisBurr, Lucy, Fanning, Steven, Wong, David and Bowler, Simon (2012). An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ Case Reports, 2012 (jul02 1), 1-4. doi: 10.1136/bcr-03-2012-5980 |
